Changzhou Qianhong Biopharma CO.,LTD
SZSE:002550.SZ
5.06 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||
Current Assets: | |||||||||||||||||
Cash & Cash Equivalents
| 576.226 | 409.257 | 617.806 | 516.11 | 202.991 | 419.527 | 186.34 | 146.237 | 166.353 | 145.301 | 561.624 | 1,219.469 | 1,364.023 | 123.309 | 99.918 | 115.615 | 83.94 |
Short Term Investments
| 136.932 | 67.476 | 68.228 | 234.284 | 662.979 | 1,324.98 | 1,582.799 | 1,267.235 | 10.247 | 10.234 | 0.363 | 0.339 | 0.37 | 0.432 | 0.464 | 0.354 | 0.684 |
Cash and Short Term Investments
| 713.157 | 476.733 | 686.034 | 750.394 | 865.971 | 419.527 | 186.34 | 146.237 | 176.599 | 155.535 | 561.987 | 1,219.807 | 1,364.392 | 123.741 | 100.382 | 115.969 | 84.623 |
Net Receivables
| 293.011 | 663.022 | 473.907 | 489.549 | 972.692 | 387.744 | 312.251 | 287.722 | 319.092 | 286.118 | 199.98 | 198.819 | 148.812 | 112.945 | 132.608 | 89.53 | 59.852 |
Inventory
| 602.01 | 536.483 | 400.63 | 315.97 | 245.864 | 245.833 | 195.059 | 171.302 | 113.003 | 137.181 | 184.911 | 151.026 | 203.11 | 219.424 | 202.731 | 88.137 | 43.312 |
Other Current Assets
| 17.776 | 11.047 | 9.37 | 1.111 | 4.786 | 1,328.471 | 1,588.037 | 1,269.401 | 1,567.486 | 1,019.368 | 572.685 | 196.931 | 0.218 | 0.16 | 0.125 | 0.121 | 0.139 |
Total Current Assets
| 1,625.955 | 1,687.284 | 1,569.942 | 1,557.024 | 2,089.313 | 2,381.575 | 2,281.686 | 1,874.663 | 2,176.18 | 1,598.202 | 1,519.562 | 1,766.584 | 1,716.532 | 456.27 | 435.845 | 293.757 | 187.927 |
Non-Current Assets: | |||||||||||||||||
Property, Plant & Equipment, Net
| 564.284 | 616.388 | 611.765 | 599.563 | 617.203 | 605.789 | 627.61 | 657.786 | 550.079 | 311.469 | 201.122 | 116.004 | 89.526 | 77.884 | 82.192 | 83.893 | 85.202 |
Goodwill
| 11.135 | 11.135 | 11.135 | 11.135 | 11.135 | 11.135 | 11.135 | 11.135 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 183.301 | 138.533 | 131.728 | 126.173 | 123.474 | 125.298 | 83.114 | 88.393 | 84.725 | 86.665 | 89.89 | 42.371 | 43.944 | 12.429 | 12.737 | 13.046 | 13.356 |
Goodwill and Intangible Assets
| 194.436 | 149.668 | 142.863 | 137.308 | 134.609 | 136.433 | 94.249 | 99.528 | 84.725 | 86.665 | 89.89 | 42.371 | 43.944 | 12.429 | 12.737 | 13.046 | 13.356 |
Long Term Investments
| 203.22 | 89.306 | -27.668 | -227.576 | -655.442 | 23.594 | 23.81 | 23.23 | 7.856 | 9.318 | 3.212 | 0.05 | 0.042 | 0.066 | 0.089 | 0.164 | 0 |
Tax Assets
| 90.527 | 101.487 | 99.418 | 105.518 | 36.384 | 19.308 | 14.882 | 14.902 | 14.263 | 5.051 | 2.465 | 2.33 | 3.1 | 1.843 | 2.971 | 0.847 | 1.678 |
Other Non-Current Assets
| 87.661 | 161.805 | 112.077 | 279.942 | 712.22 | 11.62 | 2.068 | 363.766 | 0.035 | 300.035 | 250.035 | 0.035 | 0.035 | 0.035 | 0.035 | 0.035 | 0.4 |
Total Non-Current Assets
| 1,140.127 | 1,118.654 | 938.456 | 894.755 | 844.974 | 796.744 | 762.619 | 1,159.213 | 656.957 | 712.538 | 546.723 | 160.79 | 136.647 | 92.257 | 98.022 | 97.984 | 100.635 |
Total Assets
| 2,766.081 | 2,805.938 | 2,508.398 | 2,451.779 | 2,934.287 | 3,178.319 | 3,044.305 | 3,033.875 | 2,833.138 | 2,310.739 | 2,066.285 | 1,927.374 | 1,853.179 | 548.527 | 533.868 | 391.741 | 288.562 |
Liabilities & Equity: | |||||||||||||||||
Current Liabilities: | |||||||||||||||||
Account Payables
| 41.176 | 45.972 | 71.233 | 106.247 | 62.162 | 43.978 | 56.807 | 106.606 | 96.609 | 56.77 | 37.888 | 13.652 | 6.151 | 33.17 | 32.532 | 4.615 | 0.869 |
Short Term Debt
| 56.101 | 100.095 | 89.462 | 41.851 | 344.24 | 382.36 | 384.319 | 373 | 307 | 1 | 5 | 0 | 9 | 55 | 107 | 83 | 61.15 |
Tax Payables
| 0.639 | 2.796 | 6.586 | 24.553 | 18.559 | 8.083 | 18.954 | 21.341 | 28.817 | 22.836 | 14.566 | 5.248 | 16.289 | -6.063 | 2.983 | 10.556 | -0.556 |
Deferred Revenue
| 9.706 | 15.58 | 82.438 | 103.925 | 88.451 | 8.083 | 80.35 | 64.009 | 81.622 | 62.35 | 42.428 | 0 | 37.059 | 9.075 | 121.232 | 82.752 | 13.215 |
Other Current Liabilities
| 98.828 | 116.572 | 53.216 | 38.961 | 47.134 | 120.46 | 33.745 | 29.338 | 23.411 | 23.051 | 3.609 | 37.737 | 5.464 | 2.026 | 14.87 | 3.351 | 1.633 |
Total Current Liabilities
| 205.811 | 278.219 | 296.349 | 290.984 | 541.987 | 554.881 | 555.222 | 572.953 | 508.642 | 143.171 | 88.925 | 51.389 | 57.673 | 99.271 | 275.635 | 173.718 | 76.868 |
Non-Current Liabilities: | |||||||||||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 50 | 0 | 0 | 0 | 27 | 0 | 0 | 20 | 29 | 9 | 0 | 0 |
Deferred Revenue Non-Current
| 81.846 | 89.353 | 93.422 | 94.872 | 59.077 | 34.531 | 36.184 | 36.382 | 29.991 | 7.858 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 4.516 | 4.958 | 0.466 | 0.495 | 0.586 | 0.701 | 0 | 0 | 0.037 | 0.035 | 0.058 | 0.323 | 0.037 | 0.047 | 0.051 | 0.035 | 0.084 |
Other Non-Current Liabilities
| -81.846 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.782 | 6.831 | 9.361 | 6.433 | 5.5 | 0 | 0 |
Total Non-Current Liabilities
| 4.516 | 94.311 | 93.888 | 95.367 | 59.663 | 85.231 | 36.184 | 36.382 | 30.028 | 34.893 | 6.84 | 7.155 | 29.398 | 35.48 | 14.551 | 0.035 | 0.084 |
Total Liabilities
| 210.327 | 372.53 | 390.238 | 386.351 | 601.65 | 640.112 | 591.406 | 609.335 | 538.67 | 178.064 | 95.765 | 58.543 | 87.071 | 134.751 | 290.186 | 173.753 | 76.952 |
Equity: | |||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 118.426 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 1,279.8 | 1,279.8 | 1,279.8 | 1,279.875 | 1,279.975 | 1,280 | 1,280 | 1,280 | 640 | 320 | 160 | 160 | 160 | 120 | 120 | 120 | 56 |
Retained Earnings
| 873.979 | 860.216 | 718.043 | 695.756 | 1,131.745 | 1,050.134 | 955.174 | 893.992 | 787.891 | 643.725 | 503.567 | 415.977 | 326.637 | 229.671 | 94.186 | 81.055 | 123.883 |
Accumulated Other Comprehensive Income/Loss
| 310.643 | 293.163 | 112.08 | 86.913 | -118.426 | 161.039 | 162.834 | 162.043 | 139.682 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| -9.49 | 17.175 | 17.327 | 17.445 | -79.858 | 38.614 | 39.028 | 64.589 | 706.613 | 1,135.348 | 1,270.47 | 1,251.038 | 1,234.575 | 44.474 | 29.462 | 16.899 | 31.633 |
Total Shareholders Equity
| 2,454.931 | 2,450.354 | 2,127.25 | 2,079.99 | 2,331.862 | 2,529.786 | 2,437.036 | 2,400.623 | 2,274.186 | 2,099.074 | 1,934.037 | 1,827.015 | 1,721.212 | 394.145 | 243.647 | 217.954 | 211.516 |
Total Equity
| 2,473.908 | 2,433.408 | 2,118.16 | 2,065.428 | 2,332.637 | 2,538.206 | 2,452.899 | 2,424.541 | 2,294.468 | 2,132.676 | 1,970.52 | 1,868.831 | 1,766.108 | 413.775 | 243.681 | 217.988 | 211.61 |
Total Liabilities & Shareholders Equity
| 2,766.081 | 2,805.938 | 2,508.398 | 2,451.779 | 2,934.287 | 3,178.319 | 3,044.305 | 3,033.875 | 2,833.138 | 2,310.739 | 2,066.285 | 1,927.374 | 1,853.179 | 548.527 | 533.868 | 391.741 | 288.562 |